684
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
New York University Clinical Cancer Center, New York
University of Pennsylvania, Philadelphia
Allegheny General Hospital, Pittsburgh
Geisinger Medical Center, Danville
Pulmonary & Crit Care Associates of Baltimore, Baltimore
Johns Hopkins Medical Center, Baltimore
Inova Healthcare, Fairfax
Salem Chest Specialists, Winston-Salem
LeBaurer Healthcare, Greensboro
Carolinas HealthCare System, Charlotte
Charleston Research Institute, Charleston
Medical University of South Carolina, Charleston
Georgia Lung Associates, Austell
Sarasota Memorial Hospital, Sarasota
Vanderbilt-Ingram Cancer Center, Nashville
Kentuckiana Pulmonary Associates, Louisville
Cleveland Clinic, Cleveland
Henry Ford Hospital, Detroit
Beaumont Health System, Royal Oak
Virginia Piper Cancer Institute - Allina Health, Minneapolis
Mayo Clinic, Rochester
Suburban Lung Associates, Elk Grove Village
St. Luke's Medical Center, Chesterfield
Scott & White Clinic, Temple
St. Joseph's Hospital & Medical Center, Phoenix
Pulmonary Associates of Southern Arizona, Tucson
University of Southern California, Los Angeles
California Pacific Medical Center, San Francisco
Oregon Clinic, Portland
Fred Hutchinson Cancer Research Center, Seattle
Baystate Health, Springfield
University Health Network - Toronto General Hospital, Toronto
Institute Universitarie de Cardiologie et de Pneumologie, Québec
Lead Sponsor
Integrated Diagnostics
INDUSTRY